AUPH icon

Aurinia Pharmaceuticals
AUPH

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$18
12% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Jefferies
Jefferies
Maury Raycroft
100% 1-yr AUPH win rate
7 Nov ‘25 23 days ago
RBC Capital
RBC Capital
Douglas Miehm
100% 1-yr AUPH win rate
5 Nov ‘25 25 days ago